Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To evaluate the long-term clinical course and visual outcome of patients with choroideremia.
Methods: Clinical examination, a social questionnaire, and medical records review of 21 patients with choroideremia from 14 families.
Results: The mean follow-up time was 25.2 years (SD: 13.3; range 2-57 years). The mean age at symptom onset was 15.1 years (SD: 10.1; range 5-40 years). Best-corrected visual acuity was stable until the age of 35 (P = 0.96), but declined significantly faster after the age of 35 (11%/year, P = 0.001), with a high variability between individual patients. The mean age at which patients discontinued working was 48.1 years (SD: 11.7, range 25-65 years). The reason for work discontinuation was vision related in 60% of cases. Most patients (70%) reported visual field constriction as the most debilitating symptom. The authors report scleral pits and tunnels as a novel finding visible on spectral domain optical coherence tomography and ophthalmoscopy.
Conclusion: Choroideremia is a severely debilitating disease showing a rapid decline of visual acuity generally after the age of 35, but a more gradual decline for other abnormalities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/IAE.0000000000001844 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study.
Invest Ophthalmol Vis Sci
August 2025
University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Purpose: To document the time course of visual sensitivity loss in dark-adapted visual fields (DAVF). To explore longitudinal relationships between DAVF measured using two-color dark-adapted chromatic and rod function from electroretinogram (ERG) and full-field stimulus testing in the RUSH2A study.
Methods: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF V30 were measured in one eye for DAVF ancillary study participants at the RUSH2A 12-month, 24-month, 36-month and 48-month visits.
Patient experience in retinitis pigmentosa and Choroideremia- a concept elicitation study in 17 patients based on qualitative interviews.
Orphanet J Rare Dis
August 2025
DHU Sight Restore, Centre Hospitalier National d'ophtalmologie des Quinze-Vingts, Centre de Référence Maladies Rares REFERET, INSERM-DHOS CIC 1423, Paris, France.
Background: Retinitis pigmentosa (RP) and Choroideremia (CHM) are rare inherited retinal diseases (IRDs) that can lead to severe visual impairment or blindness. Despite different underlying genetic pathways, they have many progression patterns in common, first affecting the more peripheral retina and later advancing toward the central retina. Early symptoms of both diseases include night blindness, difficulty adjusting to changing levels of light, and difficulty seeing in poor contrast.
View Article and Find Full Text PDFLoss of REP-1 in retinal pigment epithelial cells leads to impaired phagosome processing and altered lysosomal pathway function.
Mol Biol Cell
September 2025
iNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Choroideremia (CHM) is a rare form of retinal degeneration caused by mutations in the ubiquitously expressed gene, encoding for Rab escort-protein-1 (REP-1). REP-1 is required for the prenylation of Rab GTPase proteins, regulators of intracellular membrane traffic, yet what specific cellular pathways are affected in CHM and how this contributes to disease progression remain unclear. Using both ARPE-19 and iPSC-derived retinal-pigmented epithelium (RPE) cells, where the gene was knocked-out using CRISPR/Cas9, we show that cells have an increased number of lysosomes.
View Article and Find Full Text PDFRHO-Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model - In Preparation for Clinical Trials.
Invest Ophthalmol Vis Sci
July 2025
Moorfields Eye Hospital, London, United Kingdom.
Purpose: The purpose of this study was to describe the largest cohort of RHO-associated retinitis pigmentosa (RP) to date, analyzing the spectrum of phenotypes, variants, disease natural history, and genotype-phenotype correlations.
Methods: Variants were classified using functional assays, animal models, and published data. Clinical assessments involved visual acuity (LogMAR), dilated fundus examinations, multimodal imaging (spectral-domain optical coherence tomography [SD-OCT] and fundus autofluorescence [FAF]), and international-standard electrophysiology.
Fundus Autofluorescence in Inherited Retinal Disease: A Review.
Cells
July 2025
Department of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami Miller, Miami, FL 33136, USA.
Fundus autofluorescence (FAF) is a non-invasive retinal imaging technique that helps visualize naturally occurring fluorophores, such as lipofuscin, and provides valuable insight into retinal diseases-particularly inherited retinal diseases (IRDs). FAF is especially useful in detecting subclinical or early-stage IRDs and in monitoring disease progression over time. In Stargardt disease, areas of decreased autofluorescence correlate with disease progression and have been proposed as a biomarker for future clinical trials.
View Article and Find Full Text PDF